OverviewChartTechnicalNewsTraderScreen

Intra Cellular Therapies Inc/  US46116X1019  /

NASDAQ
5/13/2024  9:40:22 PM Chg. +1.1000 Volume Bid5/13/2024 Ask5/13/2024 High Low
66.0600USD +1.69% 453,793
Turnover: 19.03 mill.		 66.0400Bid Size: 100 66.0800Ask Size: 200 67.2200 65.1600
GlobeNewswire 5/8 Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
GlobeNewswire 5/7 Intra-Cellular Therapies Reports First Quarter 2024 Financial Results
GlobeNewswire 4/30 Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast
GlobeNewswire 4/24 Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise o...
GlobeNewswire 4/18 Intra-Cellular Therapies Prices Public Offering of Common Stock
GlobeNewswire 4/16 Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
GlobeNewswire 4/16 Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumate...
GlobeNewswire 3/19 Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
GlobeNewswire 3/6 Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
GlobeNewswire 2/27 Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference
GlobeNewswire 2/22 Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Co...
GlobeNewswire 2/8 Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call...
GlobeNewswire 1/2 Intra-Cellular Therapies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/5/2023 Intra-Cellular Therapies Highlights Data Presentations at the American College of Neuropsychopharmac...
GlobeNewswire 11/15/2023 Intra-Cellular Therapies to Present at the 6th Annual Evercore ISI HealthCONx Conference
GlobeNewswire 11/2/2023 Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales ...
GlobeNewswire 10/31/2023 Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
GlobeNewswire 10/26/2023 Intra-Cellular Therapies to Host Third Quarter 2023 Financial Results Conference Call and Webcast
GlobeNewswire 9/20/2023 Intra-Cellular Therapies to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
GlobeNewswire 9/11/2023 Intra-Cellular Therapies Announces Presentations at Psych Congress 2023 Including Positive Results f...
GlobeNewswire 9/5/2023 Intra-Cellular Therapies to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
GlobeNewswire 3/1/2022 Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Co...
GlobeNewswire 2/22/2022 Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call...
GlobeNewswire 1/7/2022 Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Full Exercise o...
GlobeNewswire 1/5/2022 Intra-Cellular Therapies Prices Public Offering of Common Stock